Navigation Links
Biomarker Spots Which Lesions Likely to Progress to Prostate Cancer
Date:5/2/2008

Finding could help men with precancerous lesions avoid unnecessary needle biopsies

FRIDAY, May 2 (HealthDay News) -- Spanish researchers report they may have found a way to tell which suspicious prostate lesions are likely to develop into cancer.

The findings, published in the May 1 issue of Clinical Cancer Research, show a link between high-grade prostatic intraepithelial neoplasia (HG-PIN) lesions and the PTOV1 gene. The more PTOV1 the lesion expresses, the more likely cancer will develop. The report also backs the reverse -- that the lack of PTOV1 means a reduced risk of prostate cancer.

PTOV1 is a protein that researchers don't fully understand the function of, but they have previously found too much of it appears to promote the spread of cancer cells.

If subsequent studies confirm PTOV1 as a biomarker for prostate cancer, it could help men with the lesions avoid repeated needle biopsies.

"Those patients with a high PTOV1 score should undergo an immediate repeat biopsy," study author Rosanna Paciucci, a researcher at the Vall d'Hebron Hospital Research Institute in Barcelona, said in a prepared statement. But those with low PTOVI may not need to receive future "annoying and useless" biopsies, she said. "We estimate that we can save 40 percent of unnecessary biopsies -- those that are repetitively negative and contain HG-PIN lesions that do not develop into cancer."

HG-PIN, while present in most cancerous prostates, is a pre-malignant lesion and, given its association with other cancers, it is often repeatedly biopsied when found. Past studies have put the average risk of cancer being diagnosed in a HG-PIN biopsy at between 20 percent and 30 percent, the researchers said. However, none of these studies were to tell which lesions would progress to cancer, the researchers say.

Paciucci cautioned that her team's results need to be confirmed through a larger study group. "From this validation, we can expect to improve the current rate of early detection of cancer," she said.

More information

The U.S. National Cancer Institute has more about prostate cancer.



-- Kevin McKeever



SOURCE: American Association for Cancer Research, news release, May 1, 2008


'/>"/>
Copyright©2008 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. New Thomson Reuters Biomarkers Report Shines a Light on Revolutionary New Area of Drug Development
2. Biomarker May Predict Response to Cancer Therapy
3. Biomarkers may reduce need for biopsies
4. Scientists: New technique identifies molecular biomarkers for disease
5. Biomarker May Signal HIV Progression
6. Expansion of monocyte subset could serve as a biomarker for HIV progressions
7. Biomarkers and Innovation Push Global Cancer Diagnostics Market Toward $8 Billion
8. Biomarkers for Mood May Alter Psychiatric Treatments
9. UCLA researchers discover biomarkers that predict lung cancer patient response to therapy
10. Proteomic profiling shown more accurate than traditional biomarkers in identifying liver cancer
11. New developments in biomarkers for epithelial ovarian cancer
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Biomarker Spots Which Lesions Likely to Progress to Prostate Cancer
(Date:6/26/2016)... (PRWEB) , ... June 26, 2016 , ... On June ... sponsor of the 2016 Cereal Festival and World’s Longest Breakfast Table in Battle Creek, ... of the city’s history as home to some of the world’s leading providers of ...
(Date:6/25/2016)... D.C. (PRWEB) , ... June 25, 2016 , ... ... discuss health policy issues and applications at AcademyHealth’s Annual Research Meeting June 26-28, ... their work on several important health care topics including advance care planning, healthcare ...
(Date:6/25/2016)... , ... June 25, 2016 , ... As a lifelong ... Cum Laude and his M.D from the David Geffen School of Medicine at UCLA. ... to Los Angeles to complete his fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai ...
(Date:6/24/2016)... ... June 24, 2016 , ... Those who have experienced traumatic events may suffer ... unhealthy avenues, such as drug or alcohol abuse, as a coping mechanism. To avoid ... healthy coping following a traumatic event. , Trauma sufferers tend to feel a range ...
(Date:6/24/2016)... San Francisco, CA (PRWEB) , ... June 24, ... ... at CitiDent, is now offering micro-osteoperforation for accelerated orthodontic treatment. Dr. Cheng has ... , self-ligating Damon brackets , AcceleDent, and accelerated osteogenic orthodontics. , ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... , June 23, 2016 Research ... Devices Global Market - Forecast to 2022" report to ... the treatment method for the patients with kidney failure, it ... excess fluid from the patient,s blood and thus the treatment ... potassium and chloride in balance. Increasing number ...
(Date:6/23/2016)... Roche (SIX: RO, ROG; OTCQX: RHHBY) announced ... BRAHMS PCT (procalcitonin) assay as a dedicated testing solution ... this clearance, Roche is the first IVD company in ... sepsis risk assessment and management. PCT is ... levels in blood can aid clinicians in assessing the ...
(Date:6/23/2016)... , June 23, 2016 Bracket , a ... its next generation clinical outcomes platform, Bracket eCOA (SM) ... on June 26 – 30, 2016 in Philadelphia ... electronic Clinical Outcome Assessment product of its kind to fully ... Bracket eCOA 6.0 is a flexible platform for ...
Breaking Medicine Technology: